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PREFACE
In an editorial nearly 8 years ago, Beeson predicted that human lepto­
spirosis would be recognized more frequently in America and that further 
knowledge of the varied clinical forms would be acquired. The validity 
of this prediction is reflected in our current knowledge. In fact, a rather 
marked increase appears to have occurred in the known prevalence of 
leptospirosis in both the human and domestic animal population in the 
United States during this period as shown in the figures in this manual. 
This increase may be accounted for by a combination of at least three 
factors. Perhaps one of the most important has been the development 
and application of simpler techniques in the laboratory confirmation of 
disease and the availability of these diagnostic services in laboratories 
throughout the country. Contrary to common beliefs, leptospires can be 
cultivated readily by simple procedures that are quite practical for hospi­
tal and public health laboratories. Similarly, the development of re­
liable rapid serologic tests have simplified diagnostic procedures and 
made possible extensive epidemiological strides.
Possibly the second outstanding factor has been a greater awareness 
of the disease and its many variable clinical factors. Recent information 
indicates that leptospires are involved in many cases of aseptic meningitis 
and afe not an infrequent cause of “fever of unknown origin” (FUO). 
An increasing number of laboratories are now testing serums for lepto- 
spiral antibodies which were submitted for viral serology and found 
negative. This practice has been highly productive.
Of equal importance is the epidemiological picture. It has been estab­
lished that the epidemiology of the leptospiroses will follow a charac­
teristic pattern based primarily upon the fact that they are zoonoses, 
diseases transmitted from animal to animal and from animal to human. 
Although this basic pattern has not changed, the apparent existence of 
an epizootic or panzootic period of the leptospiroses suggests changing 
environmental conditions which are more favorable to the survival of 
leptospires.
Many new wild animal hosts of leptospires are being found and, at 
present, our knowledge of the nature of the infection, the duration of the 
carrier state, and their role in the epidemiology of leptospirosis is limited. 
We must assume that they play an important part in the chain of trans­
mission until proven otherwise. Obviously, further research is needed 
to clarify the situation.
To contain these infections and prevent their spread to man, it is 
important that health workers know how to recognize and identify the
disease when it appears. This booklet, “Leptospirosis—Epidemiology, 
Clinical Manifestations, and Methods of Laboratory Diagnosis,” is an 
excellent summation of the present practical knowledge available. The 
authors, Mildred M. Galton, Robert W. Menges, Emmett B. Shotts, Jr., 
A. J. Nahmias, and Clark W. Heath, have had considerable experience 
with leptospirosis, both in the laboratory and field.
Our present knowledge of the epidemiology of leptospirosis is such 
that there is little likelihood that the disease can be eradicated or con­
trolled in the wild animal hosts which may serve as sources of infection 
for man and other animals. It is a disease that will be a problem for 
both public health and animal health authorities for years to come.
James H. Steele, D.V.M., M.P.H.
Chief,
Veterinary Public Health Section
Communicable Disease Center
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Section I
DISTRIBUTION IN THE UNITED STATES
Little progress was made in the study of leptospirosis in the United 
States for some 35 years after Stimson (1) first observed leptospires in 
sections of kidney from a patient who had died in 1905 of an illness 
believed to be yellow fever. Leptospira icterohaemorrhagiae was isolated 
from rats in New York City by Noguchi in 1917 (2), and 5 years later, 
the first human infection with L. icterohaemorrhagiae was reported by 
Wadsworth (3). A review of the American literature by Larson in 1941 
(4) revealed 93 reported cases of Weil’s disease. Infections with L. 
canicola were recognized in dogs in 1937 and man in 1938 by Meyer et al. 
(5, 6) in California. In recent years, many sporadic human cases of 
“canicola fever” and two rather large waterborne epidemics (7, 8) have 
occurred. Infections in dogs are widespread as evidenced by the estimate 
that 25 percent of dogs in this country now have leptospirosis or have 
already had it, and 25 to 50 percent of these animals become temporary 
carriers (9).
Leptospires in tissues of cattle were observed in 1944 by Jungherr {10) 
in Connecticut. Four years later, they were first isolated from bovine 
cases of leptospirosis in New Jersey by Baker and Litde (72) and identi­
fied as L. pomona by Gochenour et al. {12). About this time, Beeson (13) 
reported the first case of “aseptic meningitis” due to L. pomona infection. 
The following year, a waterborne outbreak attributed to L. pomona and 
involving about 50 persons was reported by Schaeffer {14) in Alabama. 
In addition, three outbreaks occurred in Georgia between 1940 and 1949 
{15,16) that were diagnosed in retrospect. More recently, two small 
outbreaks in which L. pomona was implicated occurred in Florida {17) 
and South Dakota {18) and a large outbreak involving more than 40 
persons was investigated in Iowa {19). In this most recent outbreak in 
Iowa, L. pomona was isolated from both human cases and from the urine 
of cattle that had access to the stream where the patients had been swim­
ming. All of these waterborne leptospiral outbreaks followed a similar 
pattern. They occurred in the middle or late summer; there was presumed 
contamination of a stagnant pond or slow-moving creek by urine from 
infected animals, and subsequent transmission to humans resulted from 
immersion in the contaminated water. The patients were young, primarily 
children ranging in age from 5 to 16 years, but with some young adults.
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An outbreak of pretibial fever occurred among troops at Fort Bragg 
in August 1942, and again in the summers of 1943 and 1944 (20, 21, 22, 
23). All of the individuals involved had been quartered in the same gen­
eral area of the post. Many had gone swimming in nearby ponds, but, 
since not all had done so, the source of infection remains obscure. The 
reported outbreaks in the United States are summarized in table 1.
In recent years, reported human cases of leptospirosis in the United 
States have increased. Cases reported from 1905 to 1948 were summa­
rized by Molner et al. (24) according to geographic distribution. During 
this 43-year period there were 306 cases in 25 States, and 78 (25 percent) 
of these cases were from Michigan. In contrast, a summary of cases on 
which the Communicable Disease Center or the Division of Veterinary 
Medicine, Walter Reed Army Institute of Research, received information 
during a 7-year period (1953-60) revealed a total of 601 cases in 45 
continental States. In addition, 147 cases occurred in outbreaks reported 
between 1951 and 1960. The distribution of these cases is shown in 
figure 1 (25).
The primary problems in the United States appear to be with the more 
common types, L. icterohaemorrhagiae, L. canicola, and L. pomona, in 
domestic animals and humans. However, nine other serotypes have been 
isolated and serologic findings suggest the presence of several other 
types. L. autumnalis, the cause of “Fort Bragg fever,” was not identified 
as such until 8 years after the initial outbreak (20). Six years later, the 
first animal host for this type in the United States was detected when the 
organisms were isolated from the kidneys of raccoons trapped in south­
west Georgia (26). L. ballum has been found frequently in rural house 
mice and opossums and occasionally in rats and laboratory mice (27, 28). 
Clinical and serologic evidence of human infection due to L. ballum 
contracted from Swiss white mice has occurred among seven laboratory 
workers at the Rocky Mountain Laboratory, Hamilton, Mont. (29). The 
wide range of hosts that may harbor leptospires became even more 
apparent with the recent isolation of L. ballum from an eastern hog-nosed 
snake (Heterodon platyrhinus) caught in a mousetrap in a cattle shed 
in Illinois (30).
During cultural studies (1954-58) at the Communicable Disease Cen­
ter, Newton, Ga., Field Station on wild mammals, L. grippotyphosa was 
isolated from raccoons trapped within 60 miles of a Florida farm on 
which cattle showed antibodies to L. grippotyphosa in 1952 (31, 32). 
In addition, these studies have revealed the presence of L. pomona, L. 
australis, L. autumnalis, two serotypes that belong to the hyos serogroup, 
one of which has been designated as L. hyos bakeri (33), the other as 
L. atlantae (34), and a new subserotype of the hebdomadis serogroup, 
L. mini georgia (35) in wild mammals. One laboratory acquired human 
infection (36) with L. mini georgia has occurred and serologic evidence 
has suggested another. It is notable that 61 percent of the leptospiral
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TABLE 1
REPORTED OUTBREAKS OF LEPTOSPIROSIS IN THE UNITED STATES1
D a te  o f  Onset Location
No. of 
Cases Age Range Probable Source Serotype Involved
July, 1939 Near Philadelphia, Pa. 7 Young adult 
swles
rats ? L. i c te rohaem orrhag i ae  2
August, 1940 Wrens, Ga. 35 Av. 16 cattle L. pomona*
July, August, 
1942-43-44
Ft. Bragg, N. C. 40/yr. Young adults 
(soldiers)
unknown L. autumnalis
August, 1942 Jackson Hole, Wyo. 24** 15-19 dogs, deer or 
other animal8
L. canicola*
August, 1947 Calvary, Ca. 10 13-24 dead mule in 
creek ?
?
August, 1949 Swainsboro, Ga. 12 Young adults cattle L. pomona*
July, 1950 Geneva, Ala. 50 Adolescents & 
young adults
swine L. pomona*
July, 1952 Columbus, Ga. 26 5-20 
2 adults
swine, dogs, 
cattle
L. canicola
July-Aug.
1956
Uakpala, S. D. 3 Young adults cattle, swine, or 
wild animals
L. pomona*
July, 1958 Madison, Fla. 8 Children swine*** and 
cattle
L. pomona
Aug., 1959 Cedar Rapids, Iowa 42 Children & 
adults
cattle L. pomona
*Serologlcal evidence only.
**9 confirmed serologically
***L. pomona Isolated from swine, serologic evidence In cattle and human cases. 
2. Organisms recovered from blood of 1 fatal case.
in contaminated water.
I
p*gure 1
OCCURRENCE OF HUMAN LEPTOSPIROSIS
isolates from skunks proved to be L. pomona. Of further interest was 
the isolation of L. pomona from 2 skunks in a group of 18 animals trapped 
on a Georgia farm where 67 percent of a herd of 96 beef cattle had high 
agglutinin titers to L. pomona and 5 of the cows had aborted.
The possibility of an animal host of L. autumnalis was not investigated 
during the Fort Bragg outbreaks or after the causative agent was estab­
lished. However, in October 1957, a limited study (37) yielded lepto- 
spires from the kidneys of 10 (11.7 percent) of 84 wild animals trapped 
in this area. The infected animals included five raccoons, three gray 
foxes, and two red foxes. Three of the leptospiral strains isolated belong 
to the australis serogroup and seven are L. grippotyphosa. While an 
animal host of L. autumnalis was not established during this limited 
study, leptospiral infection among the wild animal population appeared 
more prevalent than in the southwest Georgia area. Serologic evidence 
of human infection with a member of the australis serogroup has been 
reported (38).
In Louisiana, Roth et al. (39) has found leptospires in 41 percent of 
227 wild animals. More than 50 percent of the skunks were harboring 
leptospires. Although identification of all types isolated had not been 
completed, the preliminary report included L. pomona, L. canicola, L. 
ballum, and members of the icterohaemorrhagiae, hyos, and hebdomadis 
serogroups. In addition, serologic evidence suggests the presence of L. 
bataviae infection in humans (40), L. sejroe in cattle (32, 41), and L. 
grippotyphosa in humans (42) and cattle (32). Although L. sejroe has 
not been isolated from cattle in the United States, several strains of a closely 
related serotype, L. hardjo, have been obtained in Louisiana (43), Ne­
braska (44), and Pennsylvania (45), from animals both with and without 
clinical signs of disease.
EPIDEMIOLOGY
The epidemiology of the leptospiroses has been shown to follow a 
characteristic pattern based, in part, upon the fact that they are diseases 
transmitted from animal to animal and from animal to humans. The 
chain of transmission, with rare exception, stops with human infections, 
although Gordon Smith and Turner (46) suggest that in Malaya man may 
be important in introducing infection to previously uninfected places and 
host communities.
For many years, rats and dogs were considered to be the primary 
animal carriers, but, as the search for leptospires continues, the host 
range broadens. While leptospirosis is still prevalent in dogs and in­
fection in rats ranges from 30 to 60 percent, the disease is now a major 
problem in cattle and swine, and, in some areas, sheep, goats, and horses 
become infected. Further problems are presented by increasing evidence 
that indicates a wide distribution of leptospires in a variety of wild animals 
throughout the world.
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The rat is one of many rodent carriers including mice and voles (47, 48, 
49). Other wild animal reservoirs include bats, mongooses, shrews, bandi­
coots (50), jackals (51), and hedgehogs (52). In addition, in the United 
States, opossums, raccoons, skunks, foxes, wildcats, beaver, nutria, arma­
dillos, and rabbits have been infected (31, 39). In these host animals, 
leptospires will localize in the kidneys and may be found in the lumina of 
the convoluted tubules. After acute or even inapparent infection, these 
animals may become carriers and shed the organisms in their urine for 
long periods. The infected urine of these shedders serves as an important 
source of infection in man and other animals.
Certain leptospiral serotypes appear to have a primary animal host, 
but they may infect other animals. It is not unusual for a so-called pri­
mary host to become infected with other serotypes (53). For example, L. 
canicola, found principally in dogs, has been isolated from cattle (54, 55), 
swine (56), jackals (51), hedgehogs (52), and skunks (57), and serologic 
evidence suggests it may infect raccoons (58), while dogs have been found 
to harbor at least nine other serotypes, including L. pomona (59, 60, 61). 
Reported isolations of different leptospiral serotypes in the United States 
and their hosts are presented in table 2 (25).
TRANSMISSION TO MAN
In the transmission of leptospiral infections to humans, these animal 
carriers, which may become urinary shedders after acute, mild or, more 
frequently, inapparent infection, serve as important foci. A diagram illus­
trating the current pattern of the transmission of leptospirosis in the United 
States is presented in figure 2. Infection of humans and other animals 
results from direct or indirect contact with infected urine of these shedders. 
For example, direct contact may occur when individuals care for sick 
animals, fondle a pet dog, or handle the tissues of infected animals in 
abattoirs. Indirect contact occurs when the organisms are excreted in 
water or moist soil and individuals are subsequently exposed while swim­
ming, working, or otherwise coming in contact with the contaminated 
environment.
The role of arthropod vectors in the transmission of leptospirosis has 
been studied both experimentally and in nature. Several investigators 
(62, 63) have been able to infect ticks by allowing them to feed on infected 
guinea pigs or hamsters. These experimentally infected ticks transmitted 
the disease to normal animals. The isolation of L. grippotyphosa from 
the European tick, Dermacentor marginatus S., has been reported from 
Russia (64). The ticks were from cattle where leptospirosis had occurred 
among the herd. More recently, Van der Hoeden (65) has isolated L. 
canicola from Rhipicephalus sanguineus collected from a hedgehog. How­
ever, under natural circumstances, he attaches no great importance to the 
transmission of leptospirosis by ticks in Israel. Nevertheless, ticks should 
be considered as possible vectors until their significance is known in other 
areas.
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TABLE 2
LEPTOSPIRAL SEROTYPES IN THE CONTINENTAL UNITED STATES
Serotype
Original
Isolation Known Host
Occurrence
Man Dors Cattle Swine
1. L. icterohaemorrhagiae Japan
Germany
rat, mouse common occasional ? ?
2. L. canicola Netherlands dog, cattle, 
swine, skunk
occasional common rare rare
3. L. ballum Denmark mice, gray fox, 
opossum, wildcat, 
rats, raccoon, 
striped skunk, 
spotted skunk, 
rabbit
rare* 7 ? ?
4. L. grippotyphosa Russia raccoon, skunk, 
fox
rare* ? rare* ?
5. L. bataviae*! Indonesia 7 rare* ? 7 ?
6. L. autumnalis Japan opossum, raccoon rare 7 ? ?
7. L. porno na Australia cattle, swine, 
skunk, raccoon, 
wildcat, opossum, 
woodchuck
COOTTJOn rare comon
♦Serological evidence only
1. L. paidjan, a member of the bataviae serogroup, has recently been isolated from nutria in Louisiana. 
(Personal communication, Dr. E. E. Roth, Louisiana State University, Baton Rouge, La., 1962).
LEPTOSPIRAL SEROTYPZS IN THE CONTINENTAL UNITED STATES
TABLE 2— (Cont'd.)
Original Occurrence
Serotype Isolation Known Host Man Dogs Cattle Swine
8 . L. seiroe* Denmark •> rare* 7 sporadic* 7
9. L. hardio Indonesia cattle rare* ? sporadic 7
1 0 . L. mini, georgia United States opossum, raccoon, 
skunk
rare 7 7 7
1 1 . L. australis Australia raccoon, opossum, 
fox
rare* ? 7 7
1 2 . L. hyos, mitis J.* Australia ? ? ? rare* 7
13. L. hyos, bakeri United States opossum ? ? 7 7
14. L. atlantae, LT81 United States opossum, raccoon, 
skunk, fox
7 7 7 7
*Serological evidence only
Figure 2
TRANSMISSION of 
LEPTOSPIROSIS in the U.S.
CONT AMIN ATE D W A T E R S
During the acute phase of leptospirosis in lactating animals, leptospires 
may be shed in the milk, but no human cases have been attributed to drink­
ing infected milk. This may be explained by Kirschner’s (66) observation 
that whole milk is leptospirocidal and the organisms will survive in it 
only a few hours. However, as pointed out by Mitchell and Boulanger 
(67), the opportunity for spread of the disease from cow to cow by con­
taminated milking equipment should not be overlooked. In addition, dairy 
workers should be informed of the hazard in handling and feeding milk 
from affected cows.
The leptospires usually enter the body through the mucous membranes 
of the conjunctivae, the nose or the mouth, and through skin abrasions. 
It is believed, also, that entrance may be through unbroken skin if it is 
softened by long exposure to water.
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Environments that favor the survival of leptospires outside the body 
include moist soil, stagnant ponds, or slow-moving streams that are neutral 
or slightly alkaline; temperatures must be 22° C. or above. When 
these conditions exist in nature, leptospires may survive several weeks 
(68, 69). Other factors which may influence the survival of leptospires 
in water and moist soil include salinity, associated soil bacteria, and the 
chemical constitution of the soil (46).
OCCUPATIONAL HAZARDS
The leptospiroses are frequently referred to as occupational diseases. 
Certainly, opportunities for exposure are encountered more frequently by 
veterinarians, abattoir workers, sewer workers, dairy workers, animal hus- 
bandrymen, poultry- and fish-house workers, and swine herdsmen here in 
the United States. In Europe, Asia, and Australia, leptospirosis is an im­
portant health and economic problem among agricultural workers, partic­
ularly in the rice and canefields (70, 71). The apparent lack of this prob­
lem among agricultural workers in the United States may be attributed to 
higher living standards and to mechanization of industrial and agricultural 
operations. For example, in Italy the flooded ricefields are worked by 
hand laborers in their bare feet; here, the work is done mechanically. In 
the United States, also, protective clothing, boots, or heavy shoes are 
usually worn to perform such tasks on farms requiring contact with con­
taminated soil.
However, sporadic cases have been recognized with increasing fre­
quency among abattoir workers and others who have close contact with 
infected cattle or swine. During the past 6 years, information has been 
obtained regarding 318 cases of leptospirosis that occurred in 37 States 
(25). Information concerning the probable source was obtained on 205 
of the 318 cases. Of these, 81 (40 percent) had had contact with infected 
cattle or swine either in abattoirs or on farms; 40 (19 percent) had 
been drinking, swimming, or had been accidentally immersed in pre­
sumably contaminated water; 32 (15 percent) had had contact with dogs 
in their homes or in veterinary hospitals; 34 (16 percent) were exposed 
to rats, 8 (4 percent) to wild animals, and 10 (5 percent) to other animals 
or possibly contaminated environments in their occupations. The fact 
that the probable source of more than one-third of these cases was found 
to be contact with infected cattle or swine may be attributed, in part, to 
the apparent rapid spread and increase in recognition of bovine leptospi­
rosis in the United States. This disease was reported by York (72) to 
have occurred in only 12 States prior to 1951, whereas, by 1960, it had 
been recognized throughout the continental States according to data 
obtained from a summary of animal morbidity reports to the Com­
municable Disease Center, published reports and serum samples examined 
by Communicable Disease Center laboratories, as shown in figure 3. In 
1954, the U.S. Department of Agriculture, Agricultural Research Service
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Figure 3
(73), estimated that annual losses from bovine leptospirosis were over 
$112 million, or $25 million greater than losses from bovine brucellosis.
AGE, SEX, AND SEASONAL PREVALENCE
As a result of these environmental and occupational factors, the epi­
demiological pattern of human leptospiral infections has certain character­
istic features related to age, sex, and season. Although these infections 
may attack individuals of all ages, conditions are most favorable for 
infection of young adults (74). Beeson and Hankey (75) observed that 
due to the occupational factor, the leptospiroses occur most frequently 
in the United States in males above the age of 15 years. In a series of 24 
cases reported by them, the age range was 10 to 55, but 19 (79 percent) 
were under 30 years of age and only 5 of the patients were female. A 
distinct seasonal incidence was observed with 10 (41 percent) of the 
cases occurring in August. Molner et al. (24) reported a similar age, 
sex, and seasonal distribution among 78 cases studied in the Detroit area. 
In this series, 70 (90 percent) of the patients were over 20 years of 
age and 73 (93 percent) were male, providing further evidence of an 
occupational relationship. Although sporadic cases occurred through­
out the year, a definite increase was noted from August through Novem­
ber. Information regarding the age distribution of 184 of the 318 cases 
of leptospirosis previously referred to (25) revealed patients from 2 to 
73 years of age, but the majority were between the ages of 10 to 39, as 
shown in figure 4. There were only 32 (12 percent) females in the 
group. The highest incidence occurred between July and October 
(fig. 5).
These observations regarding age, sex, and seasonal distribution of the 
leptospiroses in the United States are in accord with the findings of 
European investigators, with possibly one exception. In certain agricul­
tural areas where fieldworkers are predominately women, the number of 
cases may be more numerous in females (71).
PREVENTION AND CONTROL
In the prevention and control of leptospirosis, the application of strict 
sanitary practices plays an important role. Protection of drinking water 
supplies for domestic animals from contamination, adequate drainage of 
wet, muddy farm areas, avoidance of overcrowded feedlots, and rat control 
are particularly valuable measures. The use of potentially contaminated 
waters for swimming by man should be avoided and protective clothing, 
such as gloves and boots, should be worn by workers in occupations of 
high risk. Thorough cleaning with disinfectant agents, as a sodium 
hypochlorite solution, effectively eliminates contamination from work 
areas in poultry- and other food-processing plants.
Leptospiral vaccines were first used in man in Japan in 1933 (76). 
These and subsequent ones tried in Europe caused severe clinical reactions. 
More recently, formalinized vaccines prepared by a method developed
12
Figure 4
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by Babudieri appear to have protected against infection and produced 
only mild reactions when given to ricefield workers in Italy (77) and 
Spain (78) and to agricultural workers in Poland (79). Serotypes used 
to prepare these vaccines were the most prevalent types in the respective 
area. In the United States, vaccines have not been used in man but with 
the widespread distribution of leptospirosis in our domestic and wild 
animals, vaccination of cattle, swine, and dogs in this country is becoming 
a common practice. L. pomona and a combination of L. canicola, and L. 
icterohaemorrhagiae are the only serotypes used in the preparation of com­
mercially available vaccines. Immunity develop« in 1 to 3 weeks after 
vaccination and is reported to last for varying periods up to 20 months 
(80). Consideration should be given to the development of a vaccine 
containing other serotypes known to occur in cattle and swine in the 
United States.
Dihydrostreptomycin and the tetracyclines (81, 82, 83, 84, 85) have 
been reported by some investigators to successfully eliminate the carrier 
state but their high cost usually limits their application to individual 
animals rather than on a herd basis.
While vaccination and the use of antibiotics may control leptospirosis in 
domestic animals, these methods cannot be applied to wild animal carriers. 
Neither would it be practical to attempt eradication of wild animal hosts. 
Further evidence is needed to establish the actual role of these wild animal 
hosts in the chain of transmission. Van der Hoeden (86) has stated that 
although mutual spread of leptospirosis in domestic animals in Israel is 
more conspicuous than in wild animals, the latter seem to be more essential 
to the maintenance of infection. Further study is also needed to establish 
the duration of the carrier state in these animals and to clarify their role 
in the possible transmission of the disease to man and to domestic animals. 
Certainly, establishment of immune domestic animal populations by 
vaccination, use of disinfectants (87) to destroy leptospires in contami­
nated soil and water in strategic areas and education of the human popu­
lation (particularly hunters) regarding the danger of infection through 
contact with infected urine or tissue of these wild animals will appreciably 
reduce the hazard from such foci. In addition, our efforts should be 
directed toward application of screening procedures to detect infection; 
use of direct culture techniques to isolate the leptospires so that the 
infecting serotype may be determined; development of effective prophy­
lactic and therapeutic agents; and, finally, education of the public as to 
the necessary hygienic practices.
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CLINICAL MANIFESTATIONS OF LEPTOSPIROSIS IN MAN
In 1886, Adolf Weil described a severe febrile illness marked by jaun­
dice, hepatosplenomegaly, renal involvement, and nervous symptoms. 
Since the time of this early description, our knowledge of the clinical 
manifestations of human leptospirosis has been greatly expanded. The 
syndrome of Weil’s disease can no longer be considered the typical clini­
cal form of leptospirosis. Instead, as medical awareness of the disease 
has increased and as diagnostic methods have improved, the majority of 
cases have proven to be anicteric and of less severity than classical Weil’s 
disease.
How frequently human leptospirosis occurs in the United States is not 
known. However, the disease certainly can no longer be considered 
“rare” or “exotic.” During recent years, an increasing number of spo­
radic cases {3-18, 59-61), as well as several common source outbreaks 
(19-24), of leptospirosis have been reported in the medical literature. 
In addition, serological studies have indicated that leptospiral infection 
accounts for a significant proportion (3 to 5 percent) of those illnesses 
usually diagnosed as “aseptic meningitis” or “fever of unknown origin” 
(1,62,63).
The infection of man with leptospiral organisms produces an acute 
systemic disease, resulting in a wide range of pathological lesions and 
clinical manifestations (1-18, 30, 41, 43, 56, 57, 59, 61). This diversity 
in symptoms and pathology is reflected in the difficulty with which the 
disease is diagnosed clinically and in the large number of diseases with 
which leptospirosis may be confused. Table 3 lists the various organ 
systems in which leptospiral involvement has been observed. The par­
ticular pathological lesions produced are summarized with their associ­
ated clinical and laboratory findings, and the most commonly encountered 
differential diagnoses are noted.
Despite this wide spectrum of clinical pathology, the majority of cases 
of leptospirosis display a recognizable and self-limited clinical picture. 
The onset of illness is generally abrupt, following an incubation period 
which ranges from 2 to 20 days, with an average of 7 days. The ensuing 
clinical course is often, but by no means always, clearly biphasic (fig. 6). 
The first phase, lasting somewhat less than a week, is generally marked 
by chills, high fever, headache, and myalgia. Often conjunctival suf­
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fusion is observed in this early stage, and, in more severe cases, hepatic 
and renal involvement of variable extent are present. This initial phase 
has been termed “systemic,” and it is during these early days of illness 
that leptospiral organisms are most commonly recovered from the blood 
and cerebrospinal fluid.
The second phase of illness may vary in length (up to 2 weeks) and 
generally follows an interlude of several days during which the initial 
fever and symptoms subside. Fever returns to a milder degree in the 
second phase and a sterile meningitis is commonplace. Other neurological 
lesions and uveitis are less common late manifestations. This second 
phase of illness generally corresponds to the time of increase of lepto­
spiral serum antibodies and has been called the “immune” phase (57). 
Recovery is usually rapid and complete, and both sequelae and relapses 
of illness seem rare. During the latter phase of illness, patients excrete 
leptospires in the urine. Occasionally this excretion of organisms con­
tinues as a carrier state, but seldom is' this observed beyond 2 months 
after clinical recovery.
The total duration of illness is perhaps related to clinical severity and 
usually ranges between 1 and 3 weeks. The disease may vary widely in 
severity, from merely a mild flu-like illness to a fulminating course with 
jaundice, renal insufficiency, meningitis, and death. The severity of 
illness seems to depend, in part, on the age and resistance of the patient 
and, in part, on the “virulence” of the infecting leptospiral strain. 
P’atalities are rarely seen in the absence of jaundice, and the majority of 
all cases are anicteric. Most deaths from leptospirosis occur in the 
presence of advanced hepatorenal involvement.
At least 10 leptospiral serotypes have been associated with human 
infection in the United States. It has been established that no single 
serotype produces any single disease syndrome exclusively. Hence, any 
one of these 10 serotypes can involve one or more of the several organ 
systems listed in table 3 and can produce disease over a wide range of 
severity. L. icterohaemorrhagiae often causes severe illnesses charac­
terized by j aundice and renal failure, but other serotypes can, on occasion, 
produce an identical clinical picture of equal severity.
Penicillin, streptomycin, and the tetracyclines have been used by numer­
ous investigators in the therapy of human leptospirosis (5, 18, 25, 27, 
30, 32, 37, 52, 53, 64), but the value of these antibiotics is still question­
able. However, there is suggestive evidence in animals and in humans 
(2, 28, 29) that antibiotic therapy, given in high doses {34, 36) within 
48 to 72 hours after the onset of illness, is beneficial in reducing the 
severity of illness. It would therefore appear that speed in suspecting 
and establishing the diagnosis of leptospirosis is most important if anti­
biotic therapy is to be of any benefit.
The diagnosis of human leptospirosis requires that the physician be 
aware of the disease, its clinical manifestations, and its epidemiology.
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toIO Table 3
Clinical and Pathological Manifestations of Leptospirosis in Man
Organs
Involved Pathology**
Clinical Signs and 
Symptoms Laboratory Findings
Differential
Diagnosis
Systemic Leptospiremia (? Toxemia) Fever: Often biphasic, 
may be accompanied by 
relative bradycardia. 
Chills, sweats, ma­
laise, prostration, 
anorexia, nausea and 
vomiting, joint pains, 
sore throat, weight 
10S8 .
WBC: Normal or eleva­
ted, usually with 
shift to left.
ESR: Elevated. 
Anemia: normochromic 
and normocytic. 
Leptospires may be 
isolated from the 
blood during first 
week after onset. 
Antibody titers 
rise thereafter.
Influenza 
Q fever 
Tuberculosis 
Rheumatic fever 
Brucellosis 
Rat-bite fever 
Epidemic hemorrha­
gic fever 
Malaria
Relapsing fever
Muscle Swelling of muscle fibers with 
loss of cross striations, 
vacuolation and hyalinization, 
infiltration with histiocytes, 
granulocytes, and plasma cells. 
Leptospires demonstrable by 
silver stains.
Pain and tenderness, 
especially of muscles 
of extremities and 
back.
Muscle weakness and 
stiffness.
Abdominal pain often 
due to involvement of 
abdominal muscles.
Muscle biopsy sug­
gestive
Collagen diseases
*NOTE: This table has been compiled from the literature to demonstrate the numerous pathological lesions, clini­
cal signs, and laboratory findings that may be present with leptospiral infection. In addition, this table lists 
those diseases which may be confused with leptospirosis. In any single case of leptospirosis, of course, only a 
few of the many clinical manifestations listed may appear. Those organ systems listed first are, in general, 
most commonly involved.
★★References 2, 30, 39, 40, 44-49, 54, 55, 57, 58.
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Organs
Involved Pathology
Clinical Signs and 
Symptoms Laboratory Findings
Differential
Diagnosis
Meninges
and
brain
Edema and inflammatory infil­
tration of leptomeninges.
Small hemorrhages in various 
areas of the brain occasionally. 
Perivascular round cell infil­
trations rarely.
Headache, stiff neck, 
meningismus.
Transient paralysis, 
dizziness, convulsions 
occasionally.
Delirium, disorienta­
tion, psychoses 
rarely.
CSF pressure may be 
elevated.
CSF cells (early, 
granulocytes; late, 
lymphocytes) rarely 
over 1 0 0 0.
CSF protein elevated 
(rarely over 10 0 mg%) 
CSF sugar normal. 
Fluid may be bile 
stained.
Leptospires may be 
isolated from CSF 
during first week.
Poliomyelitis 
Aseptic (viral) 
meningitides 
Bacterial menin­
gitides 
Tuberculosis 
meningitis 
Encephalitides 
(Various etiolo­
gies) 
Toxoplasmosis
Kidneys Interstitial inflammatory in­
filtration and edema of the 
cortex and medulla with de­
generative tubular changes, 
especially of the epithelium 
of convoluted tubules. 
Leptospires demonstrable by 
silver stains at all levels 
of renal tubules.
Dysuria, costoverte­
bral pain and tender­
ness.
Oliguria and anuria. 
Uremia
Albuminuria.
Hematuria and pyuria. 
Casts (hyaline, granu­
lar, cellular, bile) 
Low specific gravity 
Elevated BUN, NPN 
Electrolyte imbalance. 
Leptospires may be 
isolated from urine 
one week after onset.
Acute pyelone­
phritis 
Acute glomeru­
lonephritis 
Acute tubular 
necrosis
Liver Dissociation of liver cords. 
Portal infiltration 
Cloudy swelling of liver cells 
with frequent double and giant 
nuclei.
Inspissated bile in canaliculi. 
Kupffer cells enlarged. 
Scattered foci of hepatic cell 
necrosis.
Leptospires demonstrable by 
silver stains.
Jaundice 
Liver tenderness 
Hepatomegaly 
Abdominal pain
Liver function tests 
abnormal. (Pattern 
consistent with hepa­
tocellular type of 
jaundice)
Bilirubin elevated 
Cephalin Flocculation 
elevated 
Thymol turb. elevated 
Alkaline phosphatose 
elevated 
A/G ratio altered 
Liver biopsy not 
diagnostic
Infectious hepa­
titis 
Serum hepatitis 
Yellow fever 
Acute hepatic 
necrosis 
Obstructive 
jaundice
to4* Table 3— 3
Organs
Involved Pathology
Clinical Signs and 
Symptoms Laboratory Findings
Differential
Diagnosis
Eyes Early: Conjunctival suffusion 
Episcleritis 
Subconjunctival hemor­
rhage
Late: Uveitis(iridocyclitis, 
chorioretinitis)
Optic neuritis 
Retinal hemorrhage
Photophobia, burning of 
eyes, retro-orbital 
pain, papilledema, 
diplopia, strabismus, 
ptosis.
Scleral icterus
Leptospires may be 
isolated by anterior 
chamber puncture
Early symptoms 
may be seen with 
other acute toxic 
febrile illnesses
Uveitis (other 
causes)
Skin Macular or maculopapular 
dermatitis (May be morbilli­
form, urticarial)
Pretibial rash (May 
also occur over any 
area of body, especial­
ly trunk)
Typhoid fever 
Allergic rashes 
Syphilis 
Rickettsial di­
seases 
Measles 
Scarlet fever 
Meningococcemia 
Enteroviruses
Lungs Intra-alveolar and intersti­
tial hemorrhage.
Congestion and edema
Cough (may be produc­
tive)
Hemoptysis 
Rales with signs of 
congestion or con­
solidation.
X-ray: Small, patchy, 
localized, widely 
disseminated infil­
trations.
Larger confluent areas 
of consolidation
Pneumonitis: 
bacterial 
viral 
mycotic 
Pulmonary edema
Vascula­
ture
Hemorrhages in serous mem­
branes, skeletal muscles, 
gums, skin, liver, kidneys, 
lungs, GI tract.
Hemoptysis, hema- 
temesis, melena, 
epistaxis, petechia, 
purpura, hematuria, 
subconjunctival 
hemorrhage.
Usually normal bleed­
ing, clotting, and 
prothrombin times. 
Platelet normal.
Stool guaiac positive. 
Hematuria
Normochromic, normo- 
cytic anemia
Blood dyscrasia
;i tract Hemorrhages in stomach and 
small intestine, intersti­
tial pancreatitis
Anorexia, nausea and 
vomiting, abdominal 
pain (may be due to 
abdominal myositis).
GI hemorrhage 
Diarrhea, constipation 
(latter more common).
Stool guaiac positive. 
Amylase elevated
Cholecystitis
Appendicitis
Pancreatitis
"Surgical
abdomen"
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Table 3— 4
Organs
Involved Pathology
Clinical Signs and 
Symptoms Laboratory Findings
Differential
Diagnosis
Reticulo­
endothe­
lial
system
Spleen: R-E hyperplasia 
throughout pulp, phagocytosis 
of fragmented RBC, depletion 
of lymphocytes.
Generalized enlargement 
Lymph Nodes:/Lymphatic ves­
sels dilated and contain 
histiocytes, RBC, and 
hemoglobin.
Proliferation of endothelial 
cells and RBC phagocytosis.
Splenomegaly
Lymphadenopathy
Infectious
mononucleosis
Septicemia
Heart Interstitial myocarditis.
Foci of hyaline and granular 
degeneration.
Loss of striation in myo­
cardial fibers.
Scattered foci of necrosis.
Mural ventricular endocar­
ditis.
Arrhythmias 
Systolic murmur
EKG: non-specific 
changes, arrhythmias
Myocarditis 
(other causes)
Adrenals Hemorrhage
Interstitial inflammation 
with focal areas of 
necrosis (mainly in 
cortex)
Waterhouse-
Friderichsen
syndrome
Meningococcemia 
and other causes 
of acute adrenal 
insufficiency.
toUi
Figure 6
THE STAGES OF LEPTOSPIROSIS
First Phase 4-7 days
Second Phase
Septicemic Immune
Fever Meningitis
Headache Fever
Myalgia Uveitis
Conjunctival Suffusion Neurological Lesions
Leptospiremia Antibodies
Proteinuria Leptospiruric
From Edwards, Geo. A., and Domra, B. M. Human lep tosp iros is .  
Medicine 39:120, 1960
Reproduced with permission of authors and Medicine.
The diagnosis should be suspected particularly in any case of febrile illness 
which presents with myalgia and conjunctival suffusion, and which is 
characterized by meningeal, renal, or hepatic involvement Clinical sus­
picion should be further enhanced if there is present a history of environ­
mental or occupational contact with wild or domestic animals, directly or 
indirectly (i.e., contaminated water). Although leptospirosis in its many 
different manifestations can mimic a wide range of other human diseases, 
the correct identification of the great majority of cases can be confirmed 
if such clinical and epidemiological awareness is exercised.
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CLINICAL MANIFESTATIONS OF LEPTOSPIROSIS IN DOMESTIC 
ANIMALS
In animals, as in human beings, clinical signs and symptoms of lepto­
spirosis vary greatly and differential diagnosis is essential. For example, 
leptospirosis in cattle may resemble brucellosis, vibriosis, anaplasmosis, 
bacillary hemoglobinuria, or other infections and physiological and toxic 
disorders.
The symptoms and signs of leptospirosis observed in cattle include abor­
tion, usually during the seventh month of gestation, decreased milk pro­
duction, abnormal lacteal secretion, hemoglobinuria, icterus, anorexia, 
fever, diarrhea, anemia, loss of weight, and general depression. The 
milk frequently becomes yellowish, thickened, and blood tinged, and 
the udder may be flaccid. In many herds, abortion may be the only 
sign. Deaths are observed to occur, but rates are quite low. Generalized 
infection within an entire herd over a period of time is most often seen. 
Since cattle usually have a fairly high serological titer and are asympto­
matic at the time of abortion, it appears that abortion is not a manifes­
tation of the acute phase of bovine leptospirosis. Retention of the fetal 
membranes following abortion occurs in some animals. The course of 
the disease is variable, with fever usually persisting for 3 to 5 days and 
other signs and symptoms, as chronic weight loss and anemia, for sev­
eral weeks.
In the United States, most infections in swine are mild or asympto­
matic. Abortions and the birth of weak pigs are the most obvious and 
sometimes the only evidence of infection in swine. Metritis and lowered 
fertility have been encountered occasionally, as well as icterus, anemia, 
fever, encephalitis, hyperirritability, and incoordination. Mortality in 
mature pigs is low, but morbidity generally includes most of the herd.
In horses, the disease is characterized by fever, depression or dullness, 
and anorexia. Icterus may be observed in some animals. Many cases of 
equine leptospirosis undoubtedly occur without being observed because 
most affected horses show only mild, transient symptoms. Clinical and 
serological evidence indicate that leptospirosis and periodic ophthalmia 
(recurrent iridocyclitis) in horses are closely associated.
The clinical manifestations in the dog are extremely variable and may 
be absent, latent, subclinical, atypical, mild, or severe. The symptoms and 
signs frequently observed include depression, anorexia, vomiting, fever 
early, or a subnormal temperature late. The sclera and conjunctiva are 
usually injected and small ulcers are frequently seen along the gums and 
oral mucosa. Tonsillitis and a peculiar foul breath are commonly im­
ported. Icterus may or may not be a prominent symptom. Many animals 
are tucked up, having a tense abdominal wall and tenderness over the 
kidneys. A concurrent stiffness of the hindquarters may occur. Albu­
minuria, hematuria, and high blood urea nitrogen as the result of nephritis
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are common laboratory findings. In acute infections, mortality is usually 
high and death occurs in 2 to 4 days unless treated.
Survey studies have shown that leptospiral infection of cats occurs 
rarely and usually fails to cause recognizable clinical manifestations of 
disease.
Sheep and goats are susceptible to experimental infection with lepto- 
spires, but natural infections are uncommon and only in isolated instances 
have outbreaks been reported in which severe clinical signs were observed. 
Abortion, hematuria, jaundice, and a high mortality rate were noted in 
both species.
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Section II
GENERAL LABORATORY METHODS IN DIAGNOSIS
Leptospirosis should be considered and laboratory diagnostic aid 
sought in every febrile illness of unknown origin, particularly if the 
patient’s history indicates possible exposure to leptospires. Clinical 
manifestations which suggest aseptic meningitis, or nonparalytic polio- 
myelitis-like infections, also are caused frequently by leptospiral infections. 
Obviously, the procedures that will provide the earliest laboratory con­
firmation of the diagnosis of leptospirosis are the most desirable from 
the standpoint of patient, physician, veterinarian, and epidemiologist. 
These procedures, as in other bacterial infections, are based upon cultural 
and animal inoculation tests to isolate the leptospires, microscopic demon­
stration of leptospires in tissues or body fluids, and serological tests to 
detect leptospiral antibodies. The success and reliability of these labora­
tory tests depends largely upon their application at the proper time in 
the course of the disease and proper collection and handling of the sample 
to be examined.
1. ISOLATION PROCEDURES 
A. Direct and Indirect Culture
Contrary to common beliefs, leptospires can be readily cultivated. The 
isolation of leptospires by direct culture from the blood of patients during 
the febrile stage of illness is a comparatively simple procedure and, if 
properly executed, is by far the most reliable. If a cerebrospinal fluid 
sample is collected during the first 10 days of illness, this should be 
cultured also. Leptospires are recovered more frequently from blood 
between the 2d and 8th days of illness but isolations have been made 
occasionally as late as the 19th day. Since the number of leptospires 
in the blood in human cases is usually very limited, several tubes (3 to 5) 
of a suitable semisolid medium should be inoculated. Inoculation of 
freshly drawn blood is most desirable, but leptospires reportedly will 
remain viable up to 11 days in blood to which anticoagulants have been 
added {1, 2, 3). (Sodium oxalate, 0.5 ml. of a 1-percent solution to 
5 ml. of blood, or 1 ml. of a l'-percent solution of “liquoid” Roche in a 
sterile buffered saline solution at pH 7.5 to 5 ml. of blood.) Although 
citrate solutions are considered inhibitory by some investigators (1), 
Van Riel et al. (8) have isolated leptospires from blood of human patients, 
shipped in both the buffered “liquoid” and sodium citrate solution from
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the Belgian Congo to their laboratory in Belgium. The samples were 
en route from 4 to 11 days.
Numerous media (4, 5, 6, 7, 8, 9) have been developed for the cultiva­
tion of leptospires but there has been compartively little change from the 
original medium prepared by Noguchi (4) in 1915 and used by Inada 
and Ido to isolate the first strains (1). Basically, these media usually 
consist of a buffer solution, with or without some type of peptone and 
with or without 0.1 to 0.2 percent agar, to which rabbit serum is added 
to provide a final concentration in the medium of 5 to 10 percent. The 
pH may range from 7.2 to 7.8. Other types of serum, including bovine, 
horse, goat, and human, have been used with varying degrees of success, 
but none of these have been found to be consistently superior to rabbit 
serum.
Since clinical materials available for culture are frequently con­
taminated, a selective medium would be of inestimable value for the 
isolation of leptospires. Sulfadiazine and sulfaguanidine, in low concen­
trations, were found to inhibit some contaminating micro-organisms 
(7, 10). In recent studies, several agents have been found in low con­
centrations that exhibit little or no effect on leptospires (10, 11, 12). 
Cycloheximide (actidione) has been used successfully to inhibit fungi. 
Encouraging results have been obtained, also, with vancomycin and baci­
tracin. Certainly, careful evaluation of these agents is indicated to 
determine their efficacy for use in routine isolation of leptospires.
The recommended proportion of patient’s blood to medium varies from
1 ml. of blood to 3 ml. of medium (13) to 0.03 ml. of blood per 15 ml. of 
medium (14). In our experience, minimal amounts of inoculum have 
been more successful. Van Riel et al. (3) found that dilution of blood 
was of value. They inoculated 0.5 ml. of blood to 5 ml. of medium, then 
transferred 0.5 ml. of this mixture to a second tube containing 5 ml. of 
medium, and, finally, 0.5 ml. of mixture from the second tube to a third 
tube containing 5 ml. of medium.
Leptospires usually appear in the urine during the second week of 
the disease and may persist for 30 days or longer. Voided urine may 
be cultured directly if five to six serial dilutions are first prepared in 
sterile buffered saline or a suitable liquid leptospiral medium. If the 
sample is not diluted, overgrowth from contaminating organisms will 
occur. In such cases, inoculation into a test animal may be necessary. 
Weanling hamsters or guinea pigs are usually employed as test animals. 
More recently, gerbils (meriones) (15) and chinchillas (16) have been 
used successfully. Leptospires may be recovered also through 1- to 2-day 
old chicks (17, 18) but they appear to be slightly more refractory to 
small numbers of organisms than hamsters or guinea pigs. White mice 
have been used, but many laboratories have encountered natural infection 
with L. ballum in their mouse colonies (19). Natural infection in 
hamsters (20) and guinea pigs (21) must be considered, also. The
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susceptibility of these animals varies with the leptospiral serotype, and 
they may or may not show clinical signs of infection. Attempts must be 
made, therefore, to isolate leptospires from their blood at periodic in­
tervals after inoculation.
2. DEMONSTRATION METHODS 
A. Morphology of Leptospires
The morphologic appearance of leptospires is basically the same for all 
members of the genus Leptospira. They appear as slender thread-like 
organisms, about 0.1 micron in diameter and from 6 to 12 microns long, 
although they may be as long as 30 to 40 microns. The organism is 
tightly coiled on its long axis and the ends are usually bent like a hook, 
although on rare occasions the ends may be straight. The coils have an 
amplitude of 0.2 to 0.5 micron. Active young cultures rotate rapidly on 
their long axis. Electron micrographs have revealed an axial filament, 
through the entire length of the organism (22, 23, 24). They are highly 
motile and capable of passing Seitz E—K filters and other similar bacteri­
ological filters. Leptospires cannnot be seen in wet preparations by 
light-field microscopy, but they can be seen easily with dark-field illumina­
tion. They stain poorly with the usual bacterial stains, but may be 
stained readily by several silver impregnation techniques. A convenient 
method for negative staining with Congo Red was reported recently by 
Hoyer (25).
(1) Dark-field examinations.— During leptospiremia, leptospires may 
be found by dark-field examination of the blood or they may be detected 
in the urine after the first week of the disease. This method so frequently 
results in failure or in misdiagnosis that it should never be relied upon as 
the only diagnostic test. Usually, so few organisms are present in one 
drop of blood that they may be missed, or artifacts such as protoplasmic 
extrusions from blood cells may confuse even experienced workers. 
Dark-field examination may be used also to demonstrate leptospires in 
the blood or body fluids of inoculated guinea pigs or hamsters. How­
ever, at best, it should be considered only as an ancillary method.
(2) Silver staining.— In fatal cases, leptospires may be found in sec­
tions of liver and kidney tissue stained by Levaditi’s impregnation tech­
nique. Bridges (26) has reported recently on the satisfactory application 
of another silver staining procedure, Kerr’s improved Warthin-Starry 
technique (27). Silver staining is recommended as a useful method of 
demonstration of leptospires in aborted bovine fetuses since isolation 
attempts from fetal material are frequently unsuccessful (28). It should 
be emphazised that no differentiation as to infecting serotype can be 
made by either of these demonstration techniques.
(3) Fluorescent staining.—Limited studies indicate that fluorescent 
antibody techniques may be applied successfully to the detection of lepto­
spires in urine and tissue preparations (29, 30, 31). White and Ristic
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(29) demonstrated L. pomona in the urine of experimentally infected 
calves by staining with fluorescent-labeled antibody. Recently, White 
et al. (32) successfully applied this technique to the detection of lepto- 
spires in naturally infected dogs. The technique may prove to be a 
valuable tool for detection of leptospires in the urine, particularly from 
carrier animals.
3. SERO LO G ICAL PROCEDURES
Since isolation of leptospires from blood is usually possible only during 
the acute phase of the disease and, like animal inoculation, may require 
several weeks, laboratory diagnostic aid frequently is dependent upon 
serological demonstration of antibodies in the patient’s serum. A variety 
of tests have been developed for the serodiagnosis of leptospirosis. Prob­
ably the most widely used method has been the microscopic agglutination 
test with live antigen (agglutination-“Iysis” test). Although this test is 
time-consuming, hazardous, and the sensitivity of the living antigen is 
difficult to standardize, it still is considered the reference test for evalua­
tion of other tests. The microscopic agglutination test with killed antigens 
(formalinized) is less hazardous and the antigens usually remain stable 
for at least two weeks. While titers are somewhat lower with killed anti­
gens and cross reactivity is greater, results with the two tests compare 
favorably (33).
Within recent years, several macroscopic agglutination tests have been 
developed (34, 35, 36) which are performed easily and rapidly. They 
are of particular value in screening. The antigens are stable for at least 
12 months and results have been highly satisfactory in comparative tests 
with microscopic agglutination methods. These tests tend to show sero- 
group specificity, which means that a battery of antigens or several 
pooled antigens should be employed. During the late acute phase of 
illness, however, a high degree of cross-agglutination is usually noted. 
More recently, a latex leptospiral tube agglutination test (37, 38) has been 
developed which is read macroscopically. These antigens are reported 
to be stable for 2 years.
Other tests include the sonic-vibrated leptospiral complement-fixation 
test (39), the erythrocyte sensitizing substance (ESS) test (40), and 
the hemolytic test (HL) (41). These tests tend to be somewhat genus 
specific and require fewer antigens to detect leptospiral antibody. They 
are more difficult to perform, however, and are not practical for use in 
small laboratories.
4. INTERPRETATION OF SERO LO G IC  F IN D IN G S
In cases of leptospirosis, antibodies generally appear from the 6th to the 
12th day of disease and increase rapidly, reaching maximum titers by the 
3rd or 4th week. After infection, low agglutinin titers may persist for 
months or years. For this reason, it is frequently impossible to deter­
mine whether current leptospiral infection exists or antibodies are due
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to past experience with the disease unless at least two blood samples are 
examined, one during the early stages of illness and another 10 days to
2 weeks later to detect a rise in titer. Sérodiagnostic tests will not pro­
vide an early diagnosis, but, when carefully evaluated, together with 
clinical and epidemiological data, they are helpful in confirming active 
or past leptospiral infections.
Dependence should never be placed entirely upon serological reactions 
of the patient’s serum to determine the infecting serotype. For example, 
it is frequently observed that during the acute phase of L. icterohaemor- 
rhagiae infections paradoxical reactions may occur with other serotypes 
such as certain strains of L. sejroe, L. andaman, and others (42, 43). 
Kmety (43) has observed such reactions even with L. biflexa. Therefore, 
it is obvious that the infecting serotype can be determined with certainty 
only by isolation and serological identification of the leptospires. A 
negative reaction, even on serial samples, does not rule out the possibility 
of infection since the patient may be infected with a serotype not in­
cluded in the battery of testing antigens. It should be pointed out, 
also, that failure to demonstrate a rise in titer may not eliminate the 
possibility of current infection. There is some evidence to indicate early 
antibiotic treatment may suppress the development of leptospiral anti­
bodies so that they may appear late and show no increase or fail to appear 
entirely (44).
R E C O M M E N D E D  PROCEDURES FOR LA BO RA TO RY  D IA G N O S IS  
1. ISO LATIO N  PROCEDURES
A. Direct Culture
(1) Blood.— A blood sample should be collected aseptically during the 
first 10 days of illness before treatment with antibiotics and preferably 
when the patient is febrile. Swab the area with 70 percent alcohol before 
puncturing the vein, and use a sterile dry syringe and needle. Inoculate 
whole blood immediately into each of four tubes of Fletcher’s semisolid 
medium (8) containing 5 ml. of medium per tube.1 It is best to vary the 
number of drops of blood inoculated. Thus, inoculate one drop in one 
tube, two drops in the second, and three drops in the third and fourth tubes 
(fig. 7). Excessive amounts of blood may inhibit the growth of lepto­
spires. If excessive amounts of blood are inoculated, an additional amount 
of medium should be added to the tube. The cultures are incubated at 
28-30° C. (room temperature in the dark if a low temperature incubator 
is not available) for 5 to 6 weeks unless found to be positive earlier. In 
semisolid media, leptospires grow in a concentrated ring about 0.5 to 1 cm. 
below the surface. While this ring formation is helpful in detecting 
growth, it frequently does not develop for several weeks after inoculation
1 If culture medium is not available, sodium oxalate may be added as indicated 
in I.A., p. 33, to prevent coagulation and the blood shipped to the laboratory.
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Figure 7. Inoculation  of b lood  into Fletcher’s medium.
and occasionally not at all in the original culture. The cultures should 
therefore be examined at 7- to 10-day intervals microscopically. A large 
loopful of culture from the tube is placed on a 2- by 3-inch slide marked in 
%-inch squares, without a coverslip. The drop is examined by dark-field 
illumination technique with a low-power objective 10X and 15 X or 20 X 
wide-field oculars. Suspicious or positive cultures should be rechecked 
with a coverslip on the drop, using 450 X magnification. If a dark-field 
condenser is not available, a star diaphragm may be inserted in the Abbe 
condenser to obtain a dark background. It is important that a proper 
light source be used for dark-field work (fig. 8).
Contrary to general belief, this procedure is quite practical for hospi­
tal and public health laboratories. It involves the availability of a suit­
able semisolid medium, prompt inoculation of the patient’s blood at the 
proper time, and a maximum of four examinations of the cultures. When 
protected against dehydration by screwcaps or vaccine-type rubber stop­
pers, Fletcher’s medium may be used as long as 4 to 5 months after 
preparation. In public health laboratories, the medium may be pro­
vided to physicians or hospital laboratories on request, inoculated at the 
patient’s bedside, and the cultures returned to the laboratory by mail (with 
precaution against freezing). This procedure has proved highly suc­
cessful in the isolation of leptospires from the blood of infected dogs (45).
(2) Cerebrospinal fluid.— Spinal fluid, if collected during the first 10 
days of illness, also may be cultured by the same method as blood. An 
inoculum of 0.5 ml. to 5-6 ml. of Fletcher’s medium should be used (46).
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aFigure 8. Photom icrograph  of a  leptospiral culture from  b lood  in Fletcher's m edium: 
a. M a gn if ie d  ap p rox im ate ly  1 5 0 X ;  b. M a gn if ie d  ap p rox im ate ly  4 5 0  X .
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(3) Urine (by dilution technique).— Direct culture has been used 
successfully to isolate leptospires from voided urine from both man and 
animals if the sample is first diluted in buffered saline {47). With a 
sterile dry 2 ml. syringe and a 1-inch, 20-gauge needle, one drop of un­
diluted urine is inoculated into a tube of Fletcher’s medium. Then, with 
the same syringe, dilutions of the urine are prepared with sterile buffered 
saline as follows: Discharge all but 0.1 ml. of the undiluted urine from 
the syringe and draw 0.9 ml. of buffered saline into the syringe. Expel 
a few drops of this l-in-10 dilution of urine and inoculate one drop into 
a tube containing 5 ml. of Fletcher’s medium. Continue this procedure 
for four additional dilutions. Stuart’s base medium or simply a 0.2- 
percent peptone broth may be used also as a diluent. Bacterial con­
taminants usually appear in the undiluted urine cultures but leptospires 
in pure culture have been obtained in cultures of the same sample when 
diluted.
(4) Urine (by bladder tap).— Recently, a technique has been devel­
oped whereby urine suitable for direct culture may be obtained from 
animals by puncture of the bladder through the abdominal wall (48) 
(figs. 9a, b, c, d ) . This procedure has been used successfully on 
dogs, cats, guinea pigs, and small wild mammals, and it should be 
equally valuable for use on sheep, swine, goats, and young calves. Suc­
cessful application of needle aspiration of the bladder in human patients 
was recently reported by Monzon et al. (49) in a comparative study of 
bacterial counts of urine obtained by this method, catheterization and 
midstream-voided methods. Their results revealed a greater number 
of sterile specimens were obtained by suprapubic aspiration of the urinary 
bladder without undesirable side effects.
The animal is best held by its hindlegs with the head down, or it may 
be kept in a standing position. Swab the abdomen with 70 percent alcohol. 
With a 10 ml. sterile dry syringe and a 3-inch, 20-gauge needle, aspirate 
about 5 ml. of urine by entering the bladder along the midline and just 
anterior to the brim of the pelvis. For small dogs, a 1-inch, 20-gauge needle 
should be used. Inoculate one drop of urine immediately into each of two 
tubes of Fletcher’s semisolid medium containing 5 to 6 ml. of medium per 
tube. Then prepare two dilutions of the urine with sterile buffered saline 
solution or Stuart’s base medium beginning with 1 in 10, as described in 
(3) above, and inoculate one drop of each dilution into each of two tubes 
of medium. Studies on experimentally infected guinea pigs and field 
studies on animals have indicated that excessive amounts of urine appear 
to inhibit the growth of leptospires. The remainder of the urine may be 
examined by agglutination tests to determine the presence of urinary anti­
bodies, if desired.
This technique is very useful in determining the source of human infec­
tion, particularly if the family pet is suspected. Serologic tests will give
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Figure 9. O b ta in in g  urine by  b lad d er tap. a. From a m ale  d og  in  stan d ing  position; 
b. From m ale  d o g  in  a  suspended  position; c. From a  fem ale d og  in a  suspended  
position; d. From a  gu in e a  p ig  at necropsy.
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evidence of leptospirosis, but leptospires must be isolated from urine to 
determine whether an animal is a carrier.
(5) Tissue and urine cultures at necropsy.— Thé necropsy should be 
performed as soon after death as possible since bacterial invasion of the 
tissues and urine may occur. Prior to necropsy, dip small animals into a 
10-percent saponated cresol solution or a similar disinfectant for 10 to 
15 minutes. Human cadavers and large animals should be swabbed thor­
oughly with the solution. Use previously sterilized instruments or dip 
instruments in 95 percent alcohol and flame to sterilize. Cut along the 
midline and remove the skin. With another set of instruments, reflect the 
muscle and peritoneum to expose the viscera.
(a) Urine.— With a 2 ml. sterile dry syringe and a 1-inch, 20-gauge 
needle, aspirate urine from the bladder. Inoculate one drop of urine im­
mediately into each of two tubes of Fletcher’s medium, then dilute urine 
and inoculate as described in 1A(3) above.
(b) Kidney. — Remove portions of both kidneys or the entire kidney 
of small animals. Place the tissue in a sterile Petri dish, and determine the 
weight in grams (fig. 10). Then place the tissue in a sterile mortar with 
sterile sand and grind (fig. 11). Add 9 ml. of sterile buffered saline 
(pH 7.2) solution or Stuart’s medium for each gram of tissue to make 
a 10-percent tissue suspension and mix well (fig. 12). With a 2 ml. 
sterile dry syringe and a 1-inch, 20-gauge needle, draw off about 1 ml. of 
the kidney suspension (fig. 13) and inoculate three drops into each of two 
tube" *>f Fletcher’s medium. Expel all but 0.1 ml. of the kidney suspen­
sion, then draw 0.9 ml. of buffered saline into the syringe. Inoculate one 
drop of this diluted suspension into Fletcher’s medium and one drop onto 
a plate of Cox’s solid medium (50) or modified Stuart’s agar (51). Con­
tinue as in 1A(3) to prepare three additional dilutions and inoculate each 
dilution into semisolid and solid medium as above. The plates should be 
streaked for isolation with a sterile loop or glass spreader.
(6) Use of a g a r  plate technique.— The colonial growth of leptospires 
on several solid media has recently been described (50, 51, 52). This 
method has numerous advantages for isolation and for purification [see 
1C (2) ] of leptospires, but it should not be used alone in attempts to isolate 
from suspected infected material. Although impression and spread of 
cut tissue directly onto the plate has been used for the isolation of lepto­
spires, direct culture of serial dilutions of tissue emulsions and body 
fluids has been more successful (45,53).
Material to be cultured should be diluted serially tenfold. For most 
materials, isolated colonies of leptospires may be obtained at from 10'3 
to 10"6 dilutions. Very heavily contaminated materials should be plated 
in higher dilutions. A single inoculating loopful (4 to 5 mm. in diameter) 
of each dilution should be placed at one edge of the agar and spread over 
the entire surface of the plate with the loop or a glass spreader. The in­
oculated plates should be incubated at 30° C. overnight in an upright
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Figure 10. Rem ova l of k id ne y  from  a  gu in ea  p ig  a f necropsy.
F igure  11. P lacing k idney  in  sterile m ortar w ith  sterile sand  an d  grind ing .
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Figure 12. A d d it ion  o f diluent, sterile buffered sa line, or a  liqu id  leptospiral m edium  to
grou nd  kidney.
Figure 13. F illing  sy rin ge  w ith  k idney  suspension  to inoculate culture m edium , an d  prepare
further dilutions.
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position to allow surplus moisture to evaporate. They should then be 
sealed with either adhesive or “masking” tape and reincubated at 30° C. 
in an inverted position for 1 to 8 weeks and observed periodically for 
growth.
Colonies usually appear subsurface and spread slowly. They are bluish- 
gray-white. In low dilutions where many viable organisms are present, 
individual colonies may not be formed but leptospires appear as a bluish 
gray, subsurface haze covering most of the plate.
B. An im al Inoculation
The animals used include hamsters, guinea pigs, chicks, and gerbils. 
Hamsters appear to be the animal of choice. The same animal inoculation 
techniques may be used to isolate leptospires from blood, spinal fluid, or 
tissue if the specimen is suspected to be contaminated.
(1) Hamsters.— Three 21-day-old hamsters are each inoculated intra- 
peritoneally with 0.5-ml amounts of urine. Each hamster is anesthetized 
and bled from the heart, using a sterile, dry, 2 ml. syringe with a 94-inch, 
25-gauge needle. The best bleeding period is from the 5th to 10th day 
after inoculation. Four bleedings on the 5th, 8th, 10th, and 14th days 
postinoculation should be adequate. Immediately after blood is obtained, 
inoculate 1 to 3 drops into each of four tubes of Fletcher’s semisolid 
medium. Excessive amounts of blood should not be inoculated. The 
animals should be held for 21 days, then sacrificed, the kidneys removed, 
and a suspension prepared for direct cultures as in (5) (b). The same 
technique is used for gerbils (meriones).
(2) Gu inea pigs.— Use three weanling (4-week-old) animals of ap­
proximately 200 grams. Inoculate 0.5- to 1-ml. amounts of urine intra- 
peritoneally. Take rectal temperatures from the 3rd to 10th days. Bleed 
animals from the heart when they show fever (104° F. or greater). How­
ever, since some animals may not show a rise in temperature, the animals 
should be bled also at periodic intervals as with hamsters. On the 28th 
day, the animals can be necropsied and urine and kidney tissue cultured.
(3) Chicks.— Inoculate three 1-day-old chicks each intraperitoneally 
with 0.5-ml amounts of urine. Bleed the chicks with a 25-gauge needle 
from the heart on the 3rd or 4th, 10th, 15th, 18th, and 25th days post­
inoculation. As the chick gets larger, 20- or 22-gauge, 1-inch needles may 
be used.
C. Purification of Contam inated Cultures
If, on initial isolation, leptospiral cultures are contaminated or if stock 
cultures become contaminated, they may be purified by several methods:
(1) If there are numerous leptospires in the culture, it may be purified 
by filtration through a Swinny filter with an ST-3 filter pad and inocula­
tion of the filtrate directly into Fletcher’s or Stuart’s media. This method 
is not usually successful when only a few leptospires are present in the 
culture.
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(2) Dilution of contaminated culture and direct inoculation of each 
dilution onto ia plate of solid medium. Prepare ten fold dilutions of the 
contaminated culture in sterile buffered saline or in sterile Stuart’s medium. 
Inoculate 0.1 ml. of each dilution 10"3 through 10“7 onto a Cox agar plate, 
or Stuart’s medium with 1 percent agar added and streak for isolation.
On the solid medium, leptospiral colonies will be observed as subsurface 
colonies which may be picked quite easily by blocking out an area with 
a sterile scalpel and transfer of the block to a tube of semisolid leptospiral 
medium, or a plug may be obtained with a sterile capillary pipette for 
subculture.
(3) The contaminated culture may be inoculated intraperitoneally in 
the amount of 0.5 to 1 ml. into a hamster or guinea pig. After 10 to 15 
minutes, the animal is bled from the heart and the blood inoculated into 
several tubes of semisolid medium (1 to 3 drops of blood per 5 ml. of 
medium).
D. M aintenance of Cultures
Since methods to preserve leptospires by freezing or lyophilization have 
not produced consistently satisfactory results, cultures should be main­
tained by periodic transfer in Fletcher’s semisolid medium. This medium 
should contain rabbit serum and should not be used until it has been 
checked for ability to support growth of leptospires.
All stock strains and new isolations are subcultured to at least two 
tubes of Fletcher’s medium upon receipt in the laboratory. An inoculum 
of 0.5 ml. per 5 ml. of medium is adequate. Subsequent transfers to 
maintain the strain are made at 3-month intervals. If possible, two persons 
should each maintain a set of the stock strains independently. After 
inoculation, the cultures are incubated at 30° C. for 2 to 3 weeks, then 
checked macroscopically for growth. Usually, within this period, a ring 
of growth will appear one-half to 1 cm. below the surface of the medium. 
At this time, they may be placed in the dark at room temperature pro­
vided temperature of the storage area does not fluctuate too greatly (ap­
proximately 20°-25° C.).
It is desirable to retain at least four or five previously transferred 
reference sets in storage. If, for any reason, it is necessary to transfer 
from the current set of reference cultures, duplicate transfers should be 
made and one of these used to replace the transferred culture. Under no 
circumstance should a reference culture which has been opened be returned 
to the reference set.
Extreme caution should be taken to maintain accurate records, to 
eliminate possible errors in labeling tubes, and to prevent contamination.
2. SERO LO G ICAL PROCEDURES
A rapid macroscopic slide agglutination test (36) is used to screen 
human and animal serum samples. If this test is positive, the titer
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is determined by the microscopic agglutination test with live or forma- 
linized antigens. The 12 leptospiral strains used to prepare antigens for 
both tests are representatives of each serogroup in which there is cultural 
or serologic evidence to indicate the presence of some member of the 
group in the United States. They include the following serotypes: 
L.- ballum, S-102, L. canicola, Ruebush, L. icterohaemorrhagiae AB, 
Wijnberg, L. bataviae, Van Tienen, L. grippotyphosa, Andaman, L. 
pyrogenes, Salinem, L. autumnalis, AB Akiyami A, L. pomona, Johnson, 
L. sejroe, Mallersdorf, L. australis, Ballico, L. hyos hyos, and a recently 
isolated subserotype of the hebdomadis group, L. mini georgia (LT117). 
Serotypes representative of other serogroups are added to the battery 
for the microscopic test as desired.
Cross-agglutination studies with 17 slide test antigens and antiserums 
against 68 leptospiral serotypes or subserotypes indicated that, with most 
of the antiserums, some degree of cross-reactivity occurred with one or 
more of the battery of 12 antigens. L. cynopteri and L. celledoni anti­
serums failed to cross with any of the 12 antigens, but serums from two 
of three patients infected 1 with L. celledoni were positive in L. canicola 
and L. javanica antigens. Thus, in certain areas of the world, it may be 
desirable to include L. cynopteri, L. celledoni, and L. javanica. The 
only other exceptions were L. semerang and L. andaman; however, there 
is ample evidence which indicates that these two serotypes are more 
closely related to the saprophytic leptospires than to the pathogenic types.
A. Macroscopic Slide Agglu tination  Test
(1) Preparation of antigens.— The leptospires are grown in Stuart’s 
medium, dispensed in 500-ml. amounts in 32-ounce screwcapped pre­
scription bottles. Each bottle is inoculated with 50 ml. (1:10 ratio) of 
an actively growing 4- to 6-day-old leptospiral culture. The inoculated 
bottles are incubated in a slanted position at 28°-30° C. for 5 to 6 days, 
then the cultures are examined by dark-field microscopy for density, 
autoagglutination, and contamination. A satisfactory antigen should 
contain at least 100 to 200 organisms per high power field (10 X oculars 
and 45X objective), be free of “breeding nests,” and free of contamina­
tion. If the cultures appear satisfactory, formalin is added to a final 
concentration of 0.5 percent and they are allowed to stand for 1 to 2 hours, 
or, if desired, they may stand overnight.
The killed antigens are then centrifuged in 50 ml. tubes for 10 minutes 
at 1,500 times gravity to remove extraneous material. They are checked 
again by dark-field microscopy for autoagglutination, and only smooth, 
nonclumping cultures are used. The supernatant is transferred to 50 ml. 
plastic tubes and centrifuged in a high speed, angle head, SS—1 Servall
1 Serum from patients in Malaya made available by Dr. A. D. Alexander, Walter 
Reed Army Institute of Research.
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or similar centrifuge for 25 minutes at 5,000 times gravity to pack the 
leptospiral cells. The supernatant is carefully poured off immediately 
and the tubes allowed to drain in a slanted position.
The sedimented cells from 40 ml. of culture are resuspended in 1.5 to 
2 ml. of a sterile solution containing 0.5 percent formalin, 12 percent 
sodium chloride, and 20 percent glycerine. The antigen is mixed 15 
to 20 times using a 2 ml. Cornwall pipette with a No. 16- to 18-gauge 
needle and pooled in 6- to 8-ounce prescription bottles for further proc­
essing. If the cells fail to resuspend completely as determined by dark- 
field microscopy, the clumps are removed by centrifugation for 10 minutes 
at 1,500 times gravity.
To standardize for density, the antigens are adjusted to 25 to 27 per­
cent light transmission by the Lumetron photoelectric colorimeter with 
a No. M550 filter and a No. 6 reduction plate. Other equipment of com­
parable performance could be standardized against aliquots of the antigen 
and used. The Diagnostic Reagents Section, Communicable Disease Cen­
ter (54) recommends for standardization of density, an alternate method 
in which international units are determined according to the “ Interna­
tional Reference Preparation for Opacity” (55). This international refer­
ence preparation to which an opacity of 10 international units have been 
assigned may be obtained from:
1. Biologies Control Laboratories 
National Institutes of Health 
Bethesda, Md.
2. National Laboratories for Biological Standards 
Department of Biological Standards
Statens Seruminstitut 
Copenhagen, Denmark 
The preparation is a suspension of small particles of Pyrex glass in distilled 
water containing 1 part merthiolate per 10,000. It is stable for several 
years.
By this method, leptospiral antigens are standardized to 13 to 15 in­
ternational units, which has been found to be approximately equivalent 
to 25 to 27 percent light transmission by the Lumetron photoelectric color­
imeter or to 45 to 48 percent light transmission by the Coleman, Junior, 
instrument. Other equipment of comparable performance could be stand­
ardized against aliquots of the antigen and used. The final yield of antigen 
per liter of culture after standardization varies from 5 to 10 percent. The 
standardized antigens are then tested for sensitivity against the homo­
logous rabbit antiserums and against the 11 heterologous rabbit anti­
serums for cross-reactivity. The antigens should also be tested against 
known positive human and animal serums of varying titer and negative 
serums.
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(2) Slide test procedure.—  (a) For screening, the 12 slide antigens 
are combined into 4 pools by mixing equal portions of three antigens 
per pool, as follows:
Pool I Pool I I  Pool I I I  Pool IV
L. ballum L. bataviae L. autumnalis L. australis
L. canicola L. gripptoyphosa L. pomona L. hyos
L. icterohaemor- L. pyrogenes L. sejroe L. mini georgia
rhagiae
These antigens should be pooled in small portions, depending upon the 
volume of anticipated samples to be tested, so that fresh pools may be 
prepared every 6 to 8 weeks. The use of pooled antigens alone without 
confirmation with the single antigens is not recommended. However, 
if this is necessary, the serum should be sent to a reference laboratory 
for titration by either this test or the microscopic agglutination test with 
live antigens. A fifth pool containing L. cynopteri, L. celledoni, and 
L. javanica would be an advantage for certain areas of the world.
(b) For each pooled antigen used, place 0.01 ml. of serum to be tested 
on the glass plate (8- by 15-inch plate etched in 1-inch squares) with a 
0.2-ml. pipette. Add one drop of antigen (approximately 0.055 ml.) and 
mix thoroughly with applicator stick or toothpick, then rotate plate by 
hand five to six times (figs. 14 and 15). Place plate on mechanical rotator 
with speed regulator set for 125 r.p.m. for 4 minutes (fig. 16).
(c) Remove and read reaction (fig. 17) over a light box or any good 
indirect light with black background. Agglutination is recorded as posi­
tive (+ ) when definite clumping occurs doubtful (± ) if only slightly 
clumped, and negative ( —) if the serum-antigen mixture is evenly 
suspended.
(d) If a positive or doubtful reaction is obtained in one or more of 
the pooled antigens, the serum is then tested with the single antigens of 
the respective pools. For this test, the same procedure described in
(2) (b) is used. In reading, degree of agglutination is recorded as 4 + 
when all organisms appear clumped and the supernatant is clear; 3 + 
if approximately 75 percent of the leptospires have agglutinated; 2 + 
with 50 percent agglutination; and 1 + with 25 percent. Absence of ag­
glutination characterized by an even suspension of serum-antigen mixture 
is recorded as negative (fig. 18). The end point is taken as the last dilu­
tion showing a 1 + reaction.
(e) If a positive reaction is obtained in one or more antigens, the 
serum is diluted 1:5 and titrated against those antigens. For titrations, 
the diluted serum (1:5) is placed on the glass plate in 0.04-, 0.02-, 0.01-, 
and 0.005-ml. amounts. A drop of the desired antigen is placed on each 
drop of diluted serum, mixed, rotated, and read as above.
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Figure 14. Setting up macroscopic slide a gg lu t in a tion  test.
Figure 15. M ix in g  serum  an d  an tigen  in  the slide agg lu t ina tion  test.
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Figure 16. Rotation o f se rium -antigen  m ixture for slide  a gg lu t in a tion  test.
Figure 17. Read ing  m acroscopic slide  agg lu t ina tion  test.
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KJ LEPTOSPIRAL M A C R O S C O P IC  SLIDE AGGLUT INAT ION  TEST S H O W IN G  
NEGATIVE REACTION AND DEGREES OF POSITIVE REACTIONS
Figure 1 8
(/) If an end point is not reached and it is desired, the serum may be 
diluted 1:50 and titrated further. For this step, place the diluted serum 
(1:50) on the plate in 0.04-, 0.02-, 0.01-, and 0.005-ml. amounts and add 
one drop of the desired antigen to each drop of diluted serum, mix, rotate, 
and read as described in (2) (d ) .
In comparative studies with the microscopic agglutination test with 
formalinized antigen and the macroscopic slide test, it was found that for 
each microscopic test titer of 1:512 or above, the slide test median titer 
(36) was 5 (i.e., positive in the fifth dilution). It was found, further, 
that the slide test median titer increased gradually with the microscopic 
test titer. Thus, the slide test titer will serve as a guide to the approxi­
mate microscopic test titer and as to the number of dilutions necessary 
to set up if a microscopic titer is desired. The protocol for titration by 
slide test is shown on page 54.
During the past 3 years, serum samples received from more than 10 
suspected human cases of leptospirosis have appeared positive by the 
macroscopic slide agglutination test but failed to show a reaction with 
any of the 12 antigens in the microscopic agglutination test with live 
antigens. These initial samples were collected within 4 to 7 days after 
onset of illness. However, second serum samples requested and received 
10 days to 2 weeks later were positive by both tests in every instance. Due 
to the greater cross-reactivity, especially during the acute phase of illness, 
with killed slide test antigens than with the live antigens, the slide test is 
considered a more reliable screening procedure.
Reporting.— Reactions should be reported according to antigen, degree 
of agglutination and dilution. For example, serum reacted with L. canicola 
antigen, y7; L. ballum, Ys; L. icterohaemorrhagiae, Yu or if paired serums 
are examined:
Antigen
Serum No. 1 reaction Serum No. 2 reaction
Slide M icro­
scopic
Slide ■ M icro­
scopic
L. ballum .......................................................... 11/7 1:50 1/8 1:100
L. canicola........................................................ ± /l 1:50 1/7 1:400L. icterohaemorrhagiae.................................... 1/3 — 1/6 1:200
L. bataviae........................................................ 1/2 — 1/4 1:100
L. grippotyphosa.............................................. 1/2 — 1/4 1:100
L. pyrogenes...................................................... 1/2 — 1/4 1:50
L. autumnalis................................................... 1/3 1:100 1/4 1:200
L. pomona........................................................ 1/3 — 1/4 —
L. scjroe............................................................ 1/2 — 1/4 —
L. australis....................................................... 1/4 1/4 —
L. hyos.............................................................. 2 _ — 1/2 —
L. mini georgia................................................ 1/3
1 The degree of agglutination is indicated in the numerator and the dilution num­
ber in the denominator.
2 — =  negative in initial dilution of slide test, and negative in 1:50 dilution of 
microscopic test.
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Protocol for Titration by Slide Test
Dilution No.
Serum(ml) 
Antigen(ml) 
Actual dilution
1 2 3 4 5 6 7 8 9
undil. diluted 1:5 diluted 1:50
0. 01
1
0.04 0.02 0.01
1
0.005
10.04 0.02 0. 01
1
0. 005
0.055 0.055 0. 055 0. 055 0. 055 0. 055 0. 055 0. 055 0. 055
1:6.5 1:11.9 1:18.8 1:32.5 1:60 1:119 1:188 1:325 1:600
1:16
Dilutions 1:32
in which
reactions J____________________
may be ex- 1:64
pected by
microscopic I___________
test with 1; 128
formalized
antigen. I___
1:256
1:512>
B. Microscopic Agglu tination  Test
(1) Preparation of Antigens.— The 12 serotypes referred to under 2, 
page 47, are used routinely. However, if paired serum samples appear 
positive by the slide test and negative by the microscopic test with these 12 
antigens, a second battery of antigens should be used also. These include 
L. javanica, L. cynopteri, L. sentot, L. djasiman, L. alexi, L. borincana, and 
L. celledoni.
Leptospiral strains used for antigen production are maintained in 
Stuart’s medium and transferred every 5 days. The rapid transfer appears 
to keep the formation of “breeding nests” at a minimum. Such actively 
growing seed cultures are used in approximately 1:10 ratio to inoculate 
the desired amount of Stuarts’ medium in screwcapped prescription bottles. 
The inoculated bottles are incubated 4 to 6 days at 28°-30° C. in a slanted 
position and then examined by dark-field microscopy for density, smooth­
ness, and purity. If the antigens appear too dense, they may be diluted 
with Stuart’s medium or buffered 0.85 percent saline solution. Very dense 
antigens will be undersensitive, but, if very light, they tend to be too sensi­
tive and titers will be higher (56). A desirable antigen should contain 
100 to 200 organisms per high-power field (10X oculars and 45 X objec­
tive) . Some cultures will develop small clumps of leptospires, however, 
frequent, successive transfer tends to eliminate development of these 
aggregates. Contaminated cultures should not be used. Sensitivity of each 
lot of antigen should be checked against the homologous antiserum before 
use. A satisfactory antigen should react within a twofold dilution above 
or below the known titer of the antiserum. If a fourfold or greater dif­
ference in titer exists, it should not be used. If live antigens are to be used, 
they are ready for addition to the diluted serum. If killed antigens are to 
be used, 0.3 percent formalin is added to the cultures and they are allowed 
to stand 1 to 2 hours, then centrifugalized for 10 minutes at 1,500 times 
gravity to remove extraneous material, then tested for sensitivity against 
homologous antiserums. These formalinized antigens usually remain 
stable for 1 to 2 weeks. They should be checked with positive and nega­
tive control serums prior to use and watched closely for spontaneous 
agglutination. Although comparable, titers with the formalinized antigens 
usually appear somewhat lower than titers with live antigens. In addition, 
wider cross-reactions with heterologous serotypes occur with the killed 
antigens.
(2) Agglu tination  test procedure with live antigens.— Serial twofold 
dilutions of serum are prepared with buffered 0.85 percent saline to provide 
dilutions of 1:25 through 1:3,200 (higher, if necessary, to reach end 
point). To 0.2 ml. of each serum dilution, 0.2 ml. of antigen is added 
(fig. 19). The tubes are shaken, incubated at 30° C. for 3 hours, and 
examined. A drop from each tube is examined by dark-field microscopy 
using low-power objective and 10 X or 15 X oculars without a coverslip 
(fig. 20). The degree of agglutination or “lysis,” or both, is read as 1 + ,
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F igure 19. Setting up m icroscopic agg lu t ina tion  test.
Figure 20. Read ing  m icroscopic a gg lu t in a tion  test.
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2 + , 3 + , 4+ , or negative (figs. 21 a, b, c, d, e; 22 a, b, c, d, e). A reac­
tion is recorded as 4+ when 75 to 100 percent of the leptospires appear 
clumped, 8 + when approximately 75 percent of the organisms are agglu­
tinated, 2 + with about 50 percent agglutinated, and 1 + with at least 25 
percent agglutinated. The end point is taken as the last dilution showing 
a 2 + reaction.
a
e f
Figure 21. M icroscop ic a gg lu t in a tion  w ith  live Leptospira fiyos antigen: a. negative; 
b. 1 +  reaction; c. 2 +  reaction; d. 3 +  reaction; e. 4 +  reaction; f. m icroscopic 
a gg lu t in a tion  w ith  fo rm alin ized  L. hyos an tigen , 4 +  reaction.
(3) Agglu tination  test procedure with form alinized antigens.—
Serial twofold dilutions of serum are prepared in buffered 0.85 percent 
saline, starting with 1:12.5 through 1:3,200 (higher, if necessary) in a 
final volume of 0.2 ml. To each serum dilution, 0.2 ml. of antigen is 
added (fig. 19). The tubes are shaken, incubated in a waterbath at
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52° C. for 2 hours, and then refrigerated for 1 hour. Drops of the 
respective dilutions are placed on a slide and agglutination read as 
described above. It should be pointed out that, with formalin-killed 
antigens, the appearance of agglutination is different from that with live 
antigens. The clumps tend to be larger, and less tightly packed, giving 
a lacy appearance (fig. 21f ).
e
Figure 22. M icroscop ic a gg lu t in a tion  w ith  live Leptospira pyrogenes an tigen : a. negative; 
b. 1 -j- reaction; c. 2-\- reaction; d. 3 +  reaction; e. 4 -{- reaction.
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C. Identification of Leptospiral Serotypes
The present system of identification and classification of leptospires 
is based upon antigenic analysis. Since knowledge of the bionomics of 
leptospires is not sufficient to classify different antigenic strains as species 
according to the codes of nomenclature, Wolff and Broom (57) proposed 
the term “serotype” to designate the basic taxon based on the agglutino­
gens of the leptospires. This system has been accepted by the World 
Health Organization Study Group on Leptospirosis and the Leptospira 
Subcommittee of the International Committee on Bacteriological Nomen­
clature (58) and is considered the best available method. Based on this 
method, 60 leptospiral serotypes or subserotypes have been recognized or 
provisionally classified (table 4). More than 37 additional strains have 
been described but are not officially accepted.
(1) Screening and  grouping of unknown cultures.— A group of two 
or more leptospiral serotypes which by their serological reactions show 
close antigenic relationships are considered as a serogroup. A prelimi­
nary classification as to serogroup may be obtained by first screening 
the unknown culture with a battery of standardized rabbit antiserums 
against 12 serotypes. The microscopic agglutination test with a live 
actively growing culture in Stuart’s medium should be used. The anti­
serums should be prepared from type strains of : L. ballum, L. canicola, 
L. icterohaemorrhagiae, L. bataviae, L. grippotyphosa, L. pyrogenes, L. 
autumnalis, L. pomona, L. sejroe, L. australis, L. hyos, and L. mini georgia. 
If the culture appears negative or shows only a low titer against these 
antiserums, a secondary battery of five antiserums should be tested, includ­
ing L. javanica, L. butembo, L. borincana, L. djasiman, and L. celledoni. 
A routine diagnostic laboratory should not attempt to go further than 
this tentative classification into serogroups. The culture should then 
be sent to a leptospira reference laboratory for definitive identification 
by cross-agglutinin-absorption procedures. In the United States, such a 
definitive service may be obtained in the WHO/FAO Leptospirosis Refer­
ence Laboratory, Walter Reed Army Institute of Research, Washington,
D.C., and in the Communicable Disease Center, National Leptospirosis 
Reference Laboratory, Veterinary Public Health Section, Atlanta 22, Ga.
In performing the microscopic agglutination test, some leptospirosis 
reference laboratories (57) employ a different dilution schema. In this 
schema, the serum is diluted to provide final concentrations of 1:10, 1:30, 
1:100, 1:300, 1:1,000, 1:3,000, etc. For preliminary screening, how­
ever, it is not necessary to include the first two dilutions.
(2) Preparation of antiserums.— Normal rabbits weighing 8 to 9 
pounds are inoculated intravenously with successive doses of 1.0 ml, 2.0 
ml, 4.0 ml, and 6.0 ml. amounts of a 4- to 6-day-old culture of the desired 
leptospiral strain grown in Fletcher’s medium (1 ). The four inj ections are 
given at 5- to 7-day intervals. Six to seven days after the last inoculation, 
a small amount of blood is obtained for testing. If the homologous titer
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TABLE 4
SE R O T Y P E S  AND SU B SER O T YP E S  O F  L E P T O S P IR E S  
(M odified from WHO Zoonoses Report 1959)
SEROGROUP SEROTYPE SUBSEROTYPE TYPE STRAIN SYNONYMS SPECIES COUNTRY YEAR
icterohaemorrhagiae icterohaemorrhagiae (AB) icterohaemorrhagiae M 20 bonarensis man Japan 1914
icterohaemorrhagiae (A) incompleta RGA man France 1915
naam Naam man Indonesia 1936
mankarso Mankarso man Indonesia 1938
sarmin Sarmin man Indonesia 1930
birkini birkini Birkin man Malaya 1955
birkini smithii Smith man Malaya 1953
ndambari Ndambari man Belgian Congo 1947
javanica javanica Veldrat Batavia 46 rat Indonesia 1938
poi Poi sorex man Italy 1941
coxus Cox man Malaya 1954
canicola canicola Hond Utrecht IV Kashirskii canine Netherland 1933
schueffneri Vleermuis 90 C bat Indonesia 1938
benjamin Benjamin man Indonesia 1937
jonsis Jones man Malaya 1953
sumneri Sumner man Malaya 1955
malaya H-6 man Malaya 1951
ballum ballum ballumensis Mus 127 mouse Denmark 1943
ballum (AB) castellonis Castellón 3 man Spain 1955
pyrogenes pyrogenes Salinem febrilis man Indonesia 1924
okinawa
zanoni (australis B) Zanoni man Australia 1935
abramis Abraham man Malaya 1954
biggis Biggs man Malaya 1954
hamptoni Hampton man Malaya 1954
cynopteri cynopteri 3522 C bat Indonesia 1938
butembo Butembo man Belgian Congo 1946
sentot sentot Sentot man Indonesia 1937
autumnalis autumnalis (AB) autumnalis Akiyami A man Japan 1925
autumnalis (A) rachmati Rachmat man Indonesia 1923
bangkinang Bangkinang I man Indonesia 1929
mooris Moores man Malaya 1954
djasiman djasiman Djasiman man Indonesia 1937
australis australis (australis A) Ballico akiyami C man Australia 1937
hebdomadis C
muenchen München C-90 man Germany 1942
esposito Esposito man Australia 1954
TABLE 4M C°ntinne<l)
SEROGROUP SEROTYPE SUBSEROTYPE TYPE STRAIN SYNONYMS SPECIES COUNTRY YEAR
poraona pomona Pomona australis C 
type II 
suis
monjakov
DVB
man Australia 1937
grippotyphosa grippotyphosa Moskva V andaman B 
type CH-3 
bovis 
geffeni 
vituloeum
man Russia 1928
hebdomadis hebdomadis Hebdomadis akiyami B 
hebdomadis B
man Japan 1918
medanensis Hond HC dog Indonesia 1929
wolfii 3705 man Indonesia 1937
hardjo Hardjoprajitno man Indonesia 1938
mini mini * Sari Barthélémy man Italy 1941
mini szwajizak Szwajizak man Australia 1932
kremastos Kremastos man Australia 1952/ kabnra Kabura man Belgian Congo 1946julea Jules Tsango
Kambori, messo
man Belgian Congo 1955
• haemolytica haemolytica Marsh man Malaya 1954
haemolytica ricardi Richardson man Malaya 1954
worsfoldi Worsfold man Malaya 1953
sejroe M 84 man Denmark 1937
saxkoebing Mus 24 nin mouse Denmark 1942
borincana HS-622 man Puerto Rico 1951
bataviae bataviae
paidjan
Swart
Paidjan
mitis
mino
oryzeti
man Indonesia
Indonesia
1932
1939
semaranga semaranga Veldrat S 173 rat Indonesia 1937
andamana andamana CH 11 man Andaman Islands 1931
hyos hyos (mitis johnson) hyos Mitis Johnson perepelitsin
tarassovi
DVA T 384
man Australia 1940
hyos bakeri LT  79 opossum United States 1955
celledoni celledoni celledoni Celledoni man Australia 1952
celledoni (II) whitcombi Whitcomb man Malaya 1954
of the serum is at least 1: 12,800, the rabbits are exsanguinated. The 
serum is harvested, an equal’ volume of sterile glycerine added as a preserv­
ative, and the serum stored at 4° C. If the titer is low, another injection of 
4 to 6 ml. of antigen may be given. However, it is frequently necessary to 
try a new rabbit, as some are poor antibody producers. If any portion of 
the serum is to be used for fluorescent antibody studies, it should be 
filtered through a bacteriological filter, dispensed in small amounts, and 
frozen or lyophilized.
Many laboratories use the above procedure with a culture in liquid 
Stuart’s medium of the desired serotype, killed by the addition of 0.3 per­
cent formalin. Serums prepared by this method usually show lower titers 
and more cross-agglutination. However, antiserums prepared with killed 
antigens have proved satisfactory and, if adequate animal isolation facil­
ities are not available, this method may be used.
(3) Agglu tin in-absorption  technique.— The cross agglutination screen­
ing test will indicate the serogroup to which the strain belongs. It 
must then be tested with antiserums against all members of that serogroup. 
Agglutinin-absorption tests should be performed with each serotype in 
which cross reactions equal to 3 percent of the homologous titer have been 
obtained.
Antigens for absorption studies are prepared from 4- to 6-day-old cul­
tures grown in Stuart’s medium in 500-ml. amounts. Thirty-two-ounce 
screwcapped prescription bottles are convenient for this purpose. For 
best results, these bottles are slanted at a 45° angle during incubation. The 
cultures are killed by the addition of formalin to provide a final concen­
tration of 0.5 percent. The antigen is then centrifuged at 5,000 times 
gravity in a high-speed angle-head centrifuge for 25 minutes. The super­
natant is discarded and the leptospires from 250-ml. portions of culture 
resuspended in 1 to 2 percent of the original culture volume with a 
0.25 percent formalin buffered saline solution. One part of a 1: 10 dilu­
tion of antiserum is added to four parts of the absorbing antigen,1 mixed 
thoroughly, incubated in a 50° C. water bath for 2 hours and overnight at 
28°-30° C. The cells are removed by centrifugation and the absorbed 
serum tested for the presence of homologous antibody. It may be neces­
sary, however, to perform a second absorption. To avoid further dilution, 
the serum is added to packed cells from 250 ml. of killed antigen. The 
serum-cell mixture is incubated 2 to 3 hours at 37° C. and again tested for 
the presence of homologous antibody. Absorptions are considered com­
plete when agglutinins are completely removed by the homologous antigen. 
Microscopic agglutination tests with absorbed serums are performed with 
killed antigens. Final twofold serum dilutions of 1: 100 through 1: 25,600 
are used. Incubation and reading of the tests is described in B (3 ).
1 Wolff and Broom (57) recommend for absorption the addition of one part of serum 
that has been diluted to a standard titer of 1: 3,000 to nine parts packed cells.
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(4) Interpretation of agglu tin in -absorption  findings.— “Two strains 
are considered to belong to different serotypes if, after cross-absorption 
with adequate amounts of heterologous antigen, 10 percent or more of 
the homologous titer regularly remains in each of the 2 antisera” (57). 
If, after repeated tests, however, less than 10 percent of the homologous 
titer remains in one antiserum and 10 percent or more in the other anti­
serum after cross-absorption with adequate amounts of heterologous 
antigen, a strain is considered as a subserotype within a serotype.
The Joint WHO/FAO Expert Committee on Zoonoses (58) recommends 
that, before a new serotype is accepted as valid, the work should either 
be verified in one of the WHO/FAO leptospirosis reference laboratories, 
or, if the work has been done in a reference laboratory, the protocols of 
agglutination and agglutinin-absorption should be reviewed in a second 
reference laboratory.
W H O / F A O  LEPT O SP IRO S IS  REFERENCE L A B O R A T O R IE S *
1. Laboratory of the Queensland Department of Health and Home Affairs, Brisbane,
Queensland, Australia.
2. Instituto Superiore di Sanita, Rome, Italy.
3. Department of Viral and Rickettsial Diseases, National Institute of Health, Tokyo,
Japan.
4. Institute for Tropical Hygiene and Geographical Pathology (Royal Tropical
Institute), Amsterdam, Netherlands.
5. The Wellcome Laboratories of Tropical Medicine, London, England.
6. Division of Veterinary Medicine, Walter Reed Army Institute of Research Wash­
ington 12, D.C., USA.
♦Joint W H O /F A O  Expert Committee on Zoonoses, Second Report, W H O  Techn. Rep. Ser., No. 169, 
p. 72, 1959.
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A P P EN D IX
.]. Fletcher’s M edium  (8)
Form ula
Peptone__________________________________________________________0. 3 gm.
Beef extract______________________________________________________0. 2 gm.
Sodium chloride_________________________________________________ 0. 5 gm.
Agar_____________________________________________________________1. 5 gm.
Distilled water___________________________________________________  920 mis.1
Sterile rabbit serum_____________________________________________  8-10 percent.
1  If  the distilled water is acid, it  should be buffered before use to pH  7.4 w ith Sorensen’s buffer.
Sterilize by autoclaving the base for 15 minutes at 15 pounds pressure. 
Cool to 50° C. and add 8 to 10 percent sterile rabbit serum that has been 
warmed to 50° C. in a water bath. Mix to achieve a uniform solution. 
Dispense aseptically, and inactivate the whole medium at 56° C. for 1 
hour on the day it is dispensed and 1 hour on the following day. The 
pH of this medium need not be readjusted and should be in the range 
7.6 to 8. This medium is available in dehydrated form from Difco 
and BBL Laboratories.
The completed medium should be incubated for 24 hours at 37° C. and 
for 24 hours at 30° C. to check for sterility. To check the medium for 
ability to support growth of leptospires, inoculate minimal amount (0.1 
to 0.2 ml.) of actively growing stock strains into each lot of medium. At 
least 5, and preferably 12, serotypes should be used.
2. Stuart’s M ed ium  (7)
Form ula
Asparagine_______________________________________________________ 0.132 gm.
Ammonium chloride_____________________________________________  0. 268 gm.
Magnesium chloride .6H20 -------------------------------  0. 406 gm.
Sodium chloride__________________________________________________ 1. 808 gm.
Disodium phosphate______________________________________________  0. 666 gm.
Monopotassium phosphate________________________________________  0. 087 gm.
Phenol red_______________________________________________________ 0. 01 gm.
Distilled water___________________________________________________  995 ml.
Sterile rabbit serum______________________________________________8-10 percent.
Glycerine________________________________________________________ 5. 0 ml.
Sterilize by autoclaving at 15 pounds pressure for 15 minutes. Cool 
the base to less than 50° C. and add 8 to 10 percent sterile rabbit serum. 
Mix to obtain uniform solution and dispense aseptically. The pH of this 
medium should be from 7.4 to 7.6. This medium is available in a de­
hydrated form from Difco.
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The completed medium should be incubated for 24 hours at 37° C. 
and for 24 hours at 30° C. to check for sterility. To check the medium 
for ability to support growth of leptospires, inoculate minimal amount 
(0.1 to 0.2 ml.) of actively growing stock strains into each lot of medium. 
At least 5, and preferably 12, serotypes should be used.
For plates, 1 percent agar may be added to this medium (51).
3. Cox 's M edium  (50)
Dissolve 2 gm. Tryptose-phosphate (Tryptose or trypticase may be sub­
stituted) and 10 gm. Difco agar in 900 ml. distilled H20  in a steamer or 
over a burner, making certain there is no appreciable reduction in volume 
during heating. The pH of this base does not have to be adjusted. Dis­
pense in 90-ml. volumes in pyrex, screwcap, milk dilution bottles and 
autoclave. This base may be stored at room temperature. When needed, 
the bottles of agar base may be melted, cooled to 50° C., and after adding 
asepticaOy 10 ml. of sterile rabbit serum to each bottle, 3 Petri plates may 
be poured. The bottles of medium may be pasteurized at 56° C. in a water 
bath for 30 to 60 minutes before pouring, if desired. At least 30 ml. of the 
completed medium should be poured into each 100 mm. Petri dish. The 
rabbit serum, slightly hemolyzed, should be sterilized by filtration through 
a Seitz filter (ST—3) which has been previously flushed with buffered 
saline. Incubate plates overnight at 37° C. to check for sterility.
4. Rabbit Serum
Occasionally, the serum from a single rabbit may fail to support growth 
of leptospires. For this reason, pooled rabbit serum should be used for 
all leptospiral media. It is desirable to pool serum from at least 20 
rabbits, and preferably more. In some areas, rabbit blood may be ob­
tained from commercial slaughter plants where large numbers of animals 
are killed. The serum should be sterilized by filtration through a Seitz 
filter with sterilizing pad (ST-3). About 50 ml. of buffered saline should 
be put through the filter before the serum to neutralize the filter pad. 
Prior to use, each lot of pooled rabbit serum should be checked for the 
presence of leptospiral antibodies by the macroscopic or microscopic 
agglutination tests.
5. Buffered Saline Solution
Sterile buffered saline solution;
Ml.
Physiological saline solution (0.85 per cent)_________________________  1, 840
Sorensen’s buffer1__________________________________________________ 160
2,000
1 Sorensen’s buffer:
Sodium  phosphate (anhydrous) (NaoPHO.|)________________________________________ 8 . 33 gm.
Potassium phosphate (Monobasic) (K H 0PO 4 ) ______________________________________1.09 gm.
Distilled water___________________________________________________________________  1 liter.
F ina l pH  should be 7^>.
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Dispense in 16 oz. screw capped bottles, 200 ml. per bottle.
Autoclave at 15 lbs. pressure for 15 minutes. Determine the final pH 
after autoclaving. It should be pH 7.5.
6. Congo  Red Negative  Stain (25):
a) Congo Red, 2%  aqueous solution
b) Ethanol, 95% containing 1% (v/v) concentrated hydrochloric acid. 
Prepare smear by mixing a drop of culture of leptospires on a slide
with a drop of 2 percent aqueous Congo Red. Let smear dry, then cover 
slide with 95 percent ethanol containing 1 percent concentrated hydro­
chloric acid and leave to dry. To examine, use oil immersion lens and 
bright field lighting. The leptospires appear unstained against a dark 
blue background.
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The authors feel that the attached photographs give greater clarity 
and detail needed by anyone trying to duplicate the techniques 
shown. It is  recommended that the figures be inserted by recipients 
of PHS Publication No. 951, June 1962, as follows:
On page 38 — Figure 7. Inoculation of blood into Fletcher’s medium.
On page 41 — Figure 9. Obtaining urine by bladder tap.
On page 43 — Figure 10. Removal of kidney from a guinea pig at
necropsy.
On page 51 — Figure 16. Rotation of serum-antigen mixture for
slide agglutination test.and
Figure 17. Reading macroscopic slide agglutination 
test.
On page 56 — Figure 19. Setting up microscopic agglutination test, 
and
Figure 20. Reading microscopic agglutination test.
F ig u re  7. In o c u la t io n  o f b lood  in to  F le t c h e r 's  medium.
F ig u re  9. O b ta in in g  u rine  by b ladder tap. a. From  a m ale  d og  in s ta n d in g  p o s it io n ; 
b. From  m ale dog in a su sp e n d e d  p o s it io n ;  c. From  a fem ale dog in  a su sp e n d e d  
p o s it io n ;  d. From  a gu in ea  p ig  at n e c ro p sy .
F igu re  10. R em ova l o f k id ne y  from a gu in e a  p ig  at n e c rop sy .
F ig u re  17. R e a d in g  m ac ro sco p ic  s l id e  a g g lu t in a t io n  test.
F ig u re  20. R e a d in g  m ic ro sco p ic  a g g lu t in a t io n  test.
